ATRA icon

Atara Biotherapeutics
ATRA

Overview Fund Activity

73 hedge funds and large institutions have $493M invested in Atara Biotherapeutics in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 45 increasing their positions, 8 reducing their positions, and 6 closing their positions.

Holders
73
Holders Change
+2
Holders Change %
+2.82%
% of All Funds
1.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
45
Reduced
8
Closed
6
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
+$5K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$70.4M
2
SPC
2
Slate Path Capital
New York
$9.45M
3
ACH
3
ArrowMark Colorado Holdings
Colorado
$28.2M
4
BM
4
Bridger Management
New York
$22.9M
5
BFA
5
BlackRock Fund Advisors
California
$20.6M

Top Sellers

1
VAM
1
Visium Asset Management
New York
$0
2
UBS AM
2
UBS AM
Illinois
$25.9M
3
ARTA
3
A.R.T. Advisors
New York
$0
4
EAM
4
Eagle Asset Management
Florida
$21.9M
5
CS
5
Candriam SCA
Luxembourg
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Squarepoint
76
Squarepoint
New York
– – -16,188 Closed
Bank of Montreal
77
Bank of Montreal
Ontario, Canada
– – -798 Closed
Group One Trading
78
Group One Trading
Illinois
– – -561 Closed
LTFS
79
Ladenburg Thalmann Financial Services
Florida
$0 22 – –
SO
80
STRS Ohio
Ohio
– – – –
1 2 3
4